Table 1:
Variable | 1.5T | 3T |
---|---|---|
Sex | ||
Male (total %) | 15 (50%) | 11 (55%) |
Female (total %) | 15 (50%) | 9 (45%) |
Age (yr) | ||
Averagea | 60.3 ± 13.1 | 58.7 ± 15.7 |
Range | 23.4–91.0 | 27.3–84.5 |
Time between baseline and follow-up (days) | ||
Averagea (per patient) | 147 ± 155 | 132 ± 129 |
Range | 26–676 | 17–532 |
Number of ΔMBTs | ||
Total | 74 | 76 |
ΔMBTts | 58 | 67 |
ΔMBTos | 16 | 9 |
Averagea (per patient) | 4.4 ± 3.1 | 3.8 ± 3.9 |
ΔMBT volume (mL) | ||
Averagea | 2.4 ± 4.0 | 2.2 ± 3.8 |
Range | 4.0 × 10−3–1.9 × 101 | 2.0 × 10−2–3.0 × 101 |
ΔMBT volume change (mL) | ||
Averagea | 1.5 ± 2.2 | 2.2 ± 3.5 |
Range | 3.4 × 10−3–3.5 × 101 | 9.1 × 10−2–2.0 × 101 |
ΔMBT VCR (%) | ||
Averagea | 7.0 × 101 ± 29.5 | 7.6 × 101 ± 1.7 × 101 |
Range | 7.8 × 10−1–1.0 × 102 | 4.2–1.0 × 102 |
Average ± SD.